Role of leucocyte adhesion molecules in aminonucleoside of puromycin (PAN)-associated interstitial nephritis

Clinical and Experimental Immunology

Volumn 108, Issue 1, 1997, Pages 78-87

  Martin A ^a   Escudero, E ^a   Mampaso, F ^a,b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Adhesion molecules; Antibody treatment; Cell infiltrates; Endothelial cells; Puromycin

Indexed keywords

BETA1 INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; PUROMYCIN AMINONUCLEOSIDE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030937993     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-975.x     Document Type: Article

References (39)

1. Freuk S, Antonowicz I, Craig JM et al. Experimental nephrotic syndrome induced in rats with aminonucleoside. Renal lesions and body electrolyte composition. Proc Soc Exp Biol Med 1955; 89:424-27.
2. Ryan GB, Karnovsky MJ. An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis. Kidney Int 1975; 8:219-32.
3. Eddy AA, Michael AF. Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis. Kidney Int 1988; 33:14-23.
4. Diamond JR, Pesek I, Ruggieri S et al. Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury. Am J Physiol 1989; 257: F798-F807.
5. Eddy AA, Mcculloch L, Lin E et al. Relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol 1991; 138:1111-23.
6. Pober JS. Cytokines mediated activation of vascular endothelium. Am J Pathol 1988; 133:426-33.
7. Matsumoto K, Atkins RC. Glomerular cells and macrophages in the progression of experimental focal and segmental glomerulo-sclerosis. Am J Pathol 1989; 134:933-45.
8. Diamond JR, Pesek I. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoisde nephrosis. An immunohistochemical study. Lab Invest 1991; 64:21-28.
9. Gomez-Chiarri M, Ortiz A, Lerma JL et al. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rat. Lab Invest 1994; 70:449-59.
10. Martin A, Molina A, Bricio T et al. Passive dual immunization against tumor necrosis factor-alpha (TNFα) and IL-1β maximally ameliorates acute aminonucleoside nephrosis. Clin Exp Immunol 1994; 99:283-8.
11. Cotran RS, Gimbrone Jr MA, Bevilaqua MP et al. Induction and detection of a human endothelial activation antigen in vivo. J Exp Med 1986; 164:661-6.
12. Dustin ML, Springer TA. Lymphocyte function-associated antigen 1 (LFA-1) interaction with intercellular adhesion molecule 1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 1988; 107:321-31.
13. Ohmori Y, Wyner L, Narumi S et al. Tumor necrosis factor-α induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am J Pathol 1993; 142:861-70.
14. Camussi G, Bussolino F, Salvidio G et al. Tumor necrosis factor/ cachectina stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet activating factor. J Exp Med 1987; 166:1390-404.
15. Eddy AA, Crary GS, Michael AF. Identification of lymphohemopoietic cells in the kidneys of normal rats. Am J Pathol 1986; 129:335-42.
16. Tamatani T, Kotani M, Tanaka T et al. Molecular mechanisms underlying lymphocyte recirculation. II. Differential regulation of LFA-1 in interaction between lymphocytes and high endothelial cells. Eur J Immunol 1991; 21:855-8.
17. Tamatani T, Miyasaka M. Identification of monoclonal antibodies reactive with the rat homologue of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting vs. activated lymphocytes to high endothelial cells. Int Immunol 1990; 2:165-71.
18. Molina A, Sanchez-Madrid F, Bricio T et al. Prevention of mercuric chloride-induced nephritis in the Brown Norway rat by treatment with antibodies against the α4 integrin. J Immunol 1994; 153:2313-20.
19. Robinson AP, White TM, Mason DW. MRC OX-43: a monoclonal antibody which reacts with all vascular endothelium in the rat except that of brain capillaries. Immunology 1986; 57:231-7.
20. Mampaso F, Wilson CB. Characterization of inflamatory cells in autoimmune tubulointerstitial nephritis in rats. Kidney Int 1983; 23:448-57.
21. Cordell JL, Falini B, Erber WN et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complex). J Histochem Cytochem 1984; 32:219-29.
22. Kasten FH. Rat myocardial cells in vitro mitosis and differentiated properties. In Vitro 1972; 8:128-39.
23. Stamper HB, Wooddruff JJ. Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J Exp Immunol 1976; 144:828-33.
24. Couser WG. Mediation of glomerular immune injury. J Am Soc Nephrol 1990; 1:13-29.
25. Hora K, Satriano JA, Santiago A et al. Receptors for IgG complex activate synthesis of monocyte chemoattractant peptide-1 and colony-stimulating factor. Proc Natl Acad Sci USA 1992; 89:1745-9.
26. Saito T, Atkins RC. Contribution of mononuclear leukocytes to the progression of experimental focal glomerulosclerosis. Kidney Int 1990; 37:1076-83.
27. Wuthrich RP, Jevnikar AM, Takai F et al. Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. Am J Pathol 1990; 136:441-50.
28. Harning R, Pelletier J, Van G et al. Monoclonal antibody to ICAM-1 reduces acute autoimmune nephritis in kdkd mice. Clin Exp Immunopathol 1992; 64:129-34.
29. Hill PA, Lan HY, Nikolic-Paterson DJ et al. ICAM-1 directs migration and localization of interstitial leukocytes in experimental glomerulonephritis. Kidney Int 1994; 45:32-42.
30. Wykretowicz A, Issekutz TB. Effects of monoclonal antibody to VLA-4 on lymphocyte adherence to microvascular and aortic endothelial cells. J Mol Cell Cardiol 1993; 25:469-475.
31. Green DF, Hwang KH, Ryan US et al. Culture of endothelial cells from baboon and human glomeruli. Kidney Int 1992; 41:1506-6.
32. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990; 70:427-51.
33. Brady HR. Leukocyte adhesion molecules: potential targets for therapeutic intervention in kidney diseases. Curr Opinion Nephrol Hypertens 1993; 2:171-82.
34. Brady HR, Lamas S, Brenner BM et al. Cytokines promote neutrophil adhesion to glomerular endothelial cells by CD11/CD18-ICAM-1 interaction and leukotriene C4 generation by transcellular routes. J Am Soc Nephrol 1991; 2:534.
35. Brady HR, Serman CN. Adhesion promotes adhesion leukotriene biosynthesis during neutrophil-glomerular endothelial cell interactions: inhibition by anti-CD18 and L-selectin monoclonal antibodies. Biochem Biophys Res Commun 1992; 186:1307-14.
36. Mulligan MS, Jhonson KJ, Todd III RF et al. Requeriments for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 1993; 91:577-87.
37. Benigni A, Zoja C, Remuzzi G. Biology of disease. The renal toxicity of sustained glomerular protein traffic. J Clin Invest 1995; 73:461-8.
38. Lobb RR, Hemler ME. The pathologic role of α4 integrins in vivo. J Clin Invest 1994; 94:1722-8.
39. Meerschaert J, Furie MB. Monocytes use either CD11/CD18 or VLA-4 to migrate across human endothelium in vitro. J Immunol; 152:1915-26.